L’articolo è tratto da: J Midwifery Womens Health. 2007;52(3):262-272. © 2007 Elsevier Science, Inc.
Per vedere l’articolo in rete è necessario iscriversi gratuitamente su Medscape e digitare il titolo per la ricerca: Evidence-Based Practices for the Fetal to Newborn Transition
L’articolo completo a pagamento è reperibile sul sito: http://www.sciencedirect.com/
Effect of Maternal Analgesia on Newborn Transition
Most analgesic agents commonly used to alleviate labor pain readily transfer to the fetus via the placenta.
Usually, the effects of the analgesic agents are subtle, as most full term infants transition easily from fetus to newborn. However, some specific medications have the potential to disturb normal neonatal transition. [2]
Although there is a large body of literature on the various effects of analgesic agents, the reports of neonatal outcomes are often incomplete or inconclusive. The ethical and practical implications of assigning women to various pain management modalities make randomized control trials (RCTs) on pharmacologic management of labor pain and its effect on the neonatal transition difficult to conduct.
A comprehensive literature review (English only) using a combination of search terms (maternal analgesia, effects on newborn, newborn transition, labor drugs, newborn, epidural, first 4 hours, and neonatal outcomes) resulted in three Cochrane Reviews, [3-5] nine systematic reviews (includes RCTs and other types of studies), [6-14] six RCTs,[15-20] a case control study,[21] a retrospective cohort study,[22] and three observational studies. [23-25]
These studies compared types of parenteral opioids (dosages, route of administration, and codrugs), epidural versus parenteral opioids, epidural versus combined spinal-epidural analgesia, epidural dosing (traditional vs. light), and parenteral opioids versus epidural analgesia versus no analgesia. Neonatal outcomes in these studies include Apgar scores, umbilical cord pH, respiratory depression, neonatal sepsis evaluation, breastfeeding success, neurobehavioral effects, and admission to a neonatal special care unit.
Apgar Scores and Umbilical Cord pH Most studies report no effect of analgesic agents (parenteral opioids or epidurals with local anesthetics, with or without opioids) on Apgar scores or umbilical cord pH values. [6,11,13,14,17,20]
One systematic review[9] of RCTs and well designed prospective cohort studies found that newborns exposed to parenteral opioids (5 trials, N = 2015 infants) had a higher incidence of 1-minute Apgar score < 7 compared to newborns exposed to epidural analgesia. However, at 5 minutes, the Apgar scores did not differ significantly (6 trials, N = 2545).
In a Cochrane review by Anim-Somuah et al., [4] newborns exposed to epidural analgesia had a decreased risk of having an umbilical cord pH < 7.2 compared to newborns whose mothers had nonepidural analgesia.
However, there was no significant difference between groups in 5-minute Apgar scores. Findings from the PEOPLE study, a multicenter RCT (N = 1862), which examined delayed pushing and prolonged second stage of labor in primigravidas with continuous epidural analgesia, found lower umbilical cord pH (<7.15 venous or <7.10 arterial; RR, 2.45; 95% CI, 1.35-4.43) in the newborns whose mothers delayed the start of pushing as compared to the control group who began pushing at the start of second stage. [26]
Yet, no newborns in the delayed pushing group had any sign of perinatal asphyxia as measured by the Neonatal Morbidity Index. These data suggest that Apgar scores and umbilical cord pH are common gross measures of newborn well-being that may not adequately assess the subtle effects of maternal analgesic agents on the newborn.
Respiratory Depression
Morphine, meperidine (Demerol; Sanofi-Aventis, Bridgewater, NJ), and fentanyl are the opioids that have been studied the most in labor analgesia research. These opioids, as well as newer alternatives, such as nalbuphine (Nubain; Endo Pharmaceuticals, Chadds Ford, PA) and butorphanol (Stadol; Bristol-Meyers Squibb, New York, NY), have been associated with newborn respiratory depression. However, there is insufficient evidence to clarify the relationship between medication dosage and respiratory depression at birth. Opioids are known for their high lipid solubility, which allows rapid transfer of the drug through the placenta and into the fetus. The risk of respiratory depression is highest if birth occurs at the time of peak fetal uptake — between 1 and 4 hours after administration of drug to the mother. [27]
Naloxone (Narcan; Endo Pharmaceuticals) is currently used in clinical practice to reverse respiratory depression following administration of opioids. One systematic review reported that naloxone administration to the newborn is more common when parenteral opioids and patient-contro led opioid analgesia is used, compared to epidural analgesia. [9,18,19]
Another review found no differences in naloxone use between types of analgesia. [6]
Many of the studies included were too small to draw conclusions for clinical practice recommendations. Naloxone should not be given routinely at the time of birth. [8]
Neonatal Sepsis Evaluation
Lieberman and O’Donoghue [11] found that epidural use was associated with a higher incidence of maternal fever and subsequent neonatal sepsis evaluation. However, Capogna [7] suggested that, while the number of neonates receiving sepsis evaluations varies between institutions, there is no evidence that epidural exposure increases the incidence of neonatal sepsis.
Breastfeeding
There has been a longstanding concern about the negative impact of labor analgesic agents on breastfeeding success. Analgesic effects are known to include suckling inhibition, delay in the establishment of breastfeeding, decreased neonatal alertness, and diminished neurobehavioral function. [6,12]
However, most of these effects were noted in observational studies that were published more than 30 years ago.
In a review [10] of two prospective cohort studies done more recently (N = 2364), there was no correlation between breastfeeding success and use of either parenteral opioids or epidural/spinal analgesia during labor.
Capogna [7]reports that “theoretically,” the types and amount of epidural analgesia may affect breastfeeding success, but suggests early maternal infant bonding may have a greater effect on breastfeeding than does the type of maternal analgesic agent used during labor. The results of a small observational study (N = 28) revealed that neonates not exposed to pain medication exhibited an important prebreastfeeding behavior (spontaneously moving towards the breast and massaging the mother’s nipple), which is believed to contribute to suckling. [23]
Newborns (n = 12) in the first 120 minutes after birth, exposed to either intravenous (IV) meperidine, epidural with local anesthetic, or a combination of both had increased amounts of crying and a delay in developing breastfeeding behaviors. [23]
In a study of 129 infants, Riordan[24] found that fetal exposure to labor analgesia agents (IV opioids or epidural or IV opioids plus epidural) diminished early suckling but did not effect duration of breastfeeding through 6 weeks. Radzyminski [25] observed no difference in breastfeeding behaviors when comparing neonates exposed to ultra-low dose anesthetics via labor epidurals (n = 28) to neonates with no exposure to pain medication (n = 28). Beilin [16]reported that women (n = 58) who received an epidural with high dose fentanyl (>150 mcg) had more difficulty breastfeeding in the first 24 hours compared to women (n = 59) with either an intermediate dose (1-150 mcg) or no fentanyl (n = 60), although the difference did not reach statistical significance. Yet, at 6 weeks postpartum, a greater number of the women in Beilin’s high-dose fentanyl group were no longer breastfeeding. In a retrospective cohort study (N = 99), Volmanen [22] found that more women who had an epidural in labor described not having enough milk when compared to women without an epidural (15 vs. 6, P = .006) in the first 12 weeks postpartum. Lieberman and O’Donoghue [11] caution in their systematic review that further study is needed to evaluate breastfeeding success rates with the use of epidural analgesia.
Early Neurobehavioral Effects
Studies of the effect of maternal analgesic agents on early neonatal neurobehavior showed minimal differences in the neurobehavioral scores of newborns exposed to epidural opioids versus newborns exposed to parenteral opioids. [11]
Even results comparing epidural-exposed newborns to newborns with little or no medication exposure did not show a clear difference between groups. Beilin found lower neurobehavioral scores in newborns exposed to high versus low (or none) dose fentanyl (>150 mcg) epidurals. [16] Intravenous fentanyl just before spinal anesthesia for elective cesarean birth had no impact on neurobehavioral scores. [15]
Admission to a Neonatal Intensive Care Unit
No differences were found in neonatal intensive care unit (NICU) admissions of infants exposed to epidural versus nonepidural or no analgesia in labor [4] or in comparing epidural and combined spinal-epidural analgesia. [3]
Exposure to maternal analgesia does not appear to increase an infant’s risk for admission to the NICU. In summary, the current evidence on the safety of maternal analgesia (parenteral opioids or epidural or combined epidural/spinal) and the effects on the neonate are limited, and at times confusing, making it difficult to draw conclusions for clinical practice. Newborns not exposed to any labor analgesic agents appear to exhibit important prebreastfeeding behaviors necessary for successful suckling sooner than analgesiaexposed newborns, but the effects of labor analgesic agents on early suckling and breastfeeding duration is unclear. The long-term impact of neurobehavioral effects from maternal analgesia is uncertain. Future studies must look beyond gross measures, such as Apgar scores and umbilical cord pH, and focus on longterm neonatal outcomes, such as attachment, breastfeeding duration, and neurobehavioral effects.
References
1. Anderson G, Moore E, Hepworth J, Bergman N. Early skin-to-skin contact for mothers and their healthy newborn infants. Cochrane Database Syst Rev. 2003;(2):CD003519.
2. Briggs GG, Wan SR. Drug therapy during labor and delivery, Part 2. Am J Health Syst Pharm. 2006;63:1131-1139.
3. Hughes D, Simmons SW, Brown J, Cyna AM. Combined spinal-epidural versus epidural analgesia in labour. Cochrane Database Syst Rev. 2003;(4):CD003401.
4. Anim-Somuah M, Smyth R, Howell C. Epidural versus non-epidural or no analgesia in labour. Cochrane Database Syst Rev. 2005;(4):CD000331.
5. McGuire W, Fowlie PW. Naloxone for narcotic exposed newborn infants: Systematic review. Arch Dis Child Fetal Neonatal Ed. 2003;88:F308-F311.
6. Bricker L, Lavender T. Parenteral opioids for labor pain relief: A systematic review. Am J Obstet Gynecol. 2002;186:S94-S109.
7. Capogna G, Camorcia M. Epidural analgesia for childbirth: Effects of newer techniques on neonatal outcome. Paediatr Drugs. 2004;6:375-386.
8. Guinsburg R, Wyckoff MH. Naloxone during neonatal resuscitation: Acknowledging the unknown. Clin Perinatol. 2006;33:121-132.
9. Leighton BL, Halpern SH. The effects of epidural analgesia on labor, maternal, and neonatal outcomes: A systematic review. Am J Obstet Gynecol. 2002;186:S69-S77.
10.Halpern SH, Leighton BL. Misconceptions about neuraxial analgesia. Anesthesiol Clin North America. 2003;21:59-70.
11.Lieberman E, O’Donoghue C. Unintended effects of epidural analgesia during labor: A systematic review. Am J Obstet Gynecol. 2002;186:S31-S68.
12.Littleford J. Effects on the fetus and newborn of maternal analgesia and anesthesia: A review. Can J Anaesth. 2004;51:586-609.
13.Mardirosoff C, Dumont L, Boulvain M, Tramer MR. Fetal bradycardia due to intrathecal opioids for labour analgesia: A systematic review. BJOG. 2002;109:274-281.
14.Nystedt A, Edvardsson D, Willman A. Epidural analgesia for pain relief in labour and childbirth — a review with a systematic approach. J Clin Nurs. 2004;13:455-466.
15.Frolich MA, Burchfield DJ, Euliano TY, Caton D. A single dose of fentanyl and midazolam prior to Cesarean section have no adverse neonatal effects. Can J Anaesth. 2006;53:79-85.
16.Beilin Y, Bodian CA, Weiser J, Hossain S, Arnold I, Feierman DE, et al.. Effect of labor epidural analgesia with and without fentanyl on infant breast-feeding: A prospective, randomized, double-blind study. Anesthesiology. 2005;103:1211-1217.
17.Bolukbasi D, Sener EB, Sarihasan B, Kocamanoglu S, Tur A. Comparison of maternal and neonatal outcomes with epidural bupivacaine plus fentanyl and ropivacaine plus fentanyl for labor analgesia. Int J Obstet Anesth. 2005;14:288-293.
18.Halpern SH, Muir H, Breen TW, Campbell DC, Barrett J, Liston R, et al.. A multicenter randomized controlled trial comparing patient-controlled epidural with intravenous analgesia for pain relief in labor. Anesth Analg. 2004;99:1532-1538.
19.Jain S, Arya VK, Gopalan S, Jain V. Analgesic efficacy of intramuscular opioids versus epidural analgesia in labor. Int J Gynaecol Obstet. 2003;83:19-27.
20.Lee BB, Ngan Kee WD, Lau WM, Wong AS. Epidural infusions for labor analgesia: A comparison of 0.2% ropivacaine, 0.1% ropivacaine, and 0.1% ropivacaine with fentanyl. Reg Anesth Pain Med. 2002;27:31-36.
21.Baumgarder DJ, Muehl P, Fischer M, Pribbenow B. Effect of labor epidural anesthesia on breastfeeding of healthy full-term newborns delivered vaginally. J Am Board Fam Pract. 2003;16:7-13.
22.Volmanen P, Valanne J, Alahuhta S. Breast-feeding problems after epidural analgesia for labour: A retrospective cohort study of pain, obstetrical procedures and breast-feeding practices. Int J Obstet Anesth. 2004;13:25-29.
23.Ransjo-Arvidson A, Matthiesen A, Lilja G, Nissen E, Widstrom A, Uvnas-Moberg K. Maternal analgesia during labor disrupts newborn behavior: Effects of breastfeeding, temperature and crying. Birth. 2001;28:5-12.
24.Riordan J, Gross A, Angeron J, Krumwiede B, Melin J. The effect of labor pain relief medication on neonatal suckling and breastfeeding duration. J Hum Lact. 2000;16:7-12.
25.Radzyminski S. The effect of ultra low dose epidural analgesia on newborn breastfeeding behaviors. J Obstet Gynecol Neonatal Nurs. 2003;32:322-331.
26.Fraser WD, Marcoux S, Krausss I, Douglas J, Goulet C, Boulvain MThe PEOPLE (Pushing Early or Pushing Late with Epidural) Study Group. Multicenter, randomized, controlled trial of delayed pushing for nulliparous women in second stage of labor with continuous epidural analgesia. Am J Obstet Gynecol. 2000;182:1165-1172.
27.Poole J. Analgesia and anesthesia during labor and birth: Implications for mother and fetus. JOGNN. 2003;32:780-793.
28.Yao AC, Moinian M, Lind J. Distribution of blood between infant and placenta after birth. Lancet. 1969;2:871-873.
29.Lozoff B, Beard J, Connor J, Barbara F, Georgieff M, Schallert T. Long-lasting neural and behavioral effects of iron deficiency in infancy. Nutr Rev. 2006;64:S34-S43.
30.Mercer JS. Current best evidence: A review of the literature on umbilical cord clamping. J Midwifery Womens Health. 2001;46:402-414.
31.van Rheenen P, Brabin BJ. Late umbilical cord-clamping as an intervention for reducing iron deficiency anaemia in term infants in developing and industrialised countries: A systematic review. Ann Trop Paediatr. 2004;24:3-16.
32.Chaparro CM, Neufeld LM, Tena Alavez G, Eguia-Liz Cedillo R, Dewey KG. Effect of timing of umbilical cord clamping on iron status in Mexican infants: A randomised controlled trial. Lancet. 2006;367:1997-2004.
33.Cernadas J, Carroli G, Pellegrini L, Otano L, Ferreira M, Ricci C. The effect of timing of cord clamping on neonatal venous hematocrit values and clinical outcome at term: A randomized controlled trial. Obstetrical & Gynecolgical Survey. 2006;61:564-565.
34.Gupta R, Ramji S. Effect of delayed cord clamping on iron stores in infants born to anemic mothers: A randomized controlled trial. Indian Pediatr. 2002;39:130-135.
35.Emhamed MO, van Rheenen P, Brabin BJ. The early effects of delayed cord clamping in term infants born to Libyan mothers. Trop Doct. 2004;34:218-222.
36.Grajeda R, Perez-Escamilla R, Dewey KG. Delayed clamping of the umbilical cord improves hematologic status of Guatemalan infants at 2 mo of age. Am J Clin Nutr. 1997;65:425-431.
37.Iffy L, Varadi V, Papp E. Untoward neonatal sequelae deriving from cutting of the umbilical cord before delivery. Med Law. 2001;20:627-634.
38.Mercer JS, Skovgaard RL, Peareara-Eaves J, Bowman T. Nuchal cord management and nursemidwifery practice. J Midwifery Womens Health. 2005;50:373-379.
39.Lapidot T, Dar A, Kollet O. How do stem cells find their way home?. Blood. 2005;106:1901-1910.
40.Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J, et al.. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol. 2005;33:145-152.
41.Meier C, Middelanis J, Wasielewski B, Neuhoff S, Roth-Haerer A, Gantert M, et al.. Spastic paresis after perinatal brain damage in rats is reduced by human cord blood mononuclear cells. Pediatr Res. 2006;59:244-249.
42.American Academy of Pediatrics Work Group on Cord Blood Banking. Cord blood banking for future transplantation: Subject review. Pediatrics. 1999;104:116-118.
43.Carfoot S, Williamson P, Dickson R. A randomised controlled trial in the north of England examining the effects of skin-to-skin care on breast feeding. Midwifery. 2005;21:71-79.
44.Vaidya K, Sharma A, Dhungel S. Effect of early mother-baby close contact over the duration of exclusive breastfeeding. Nepal Med Coll J. 2005;7:138-140.
45.Fransson AL, Karlsson H, Nilsson K. Temperature variation in newborn babies: Importance of physical contact with the mother. Arch Dis Child Fetal Neonatal Ed. 2005;90:F500-F504.
46.Ferber SG, Makhoul IR. The effect of skin-to-skin contact (kangaroo care) shortly after birth on the neurobehavioral responses of the term newborn: A randomized, controlled trial. Pediatrics. 2004;113:858-865.
47.van den Bosch CA, Bullough CH. Effect of early suckling on term neonates’ core body temperature. Ann Trop Paediatr. 1990;10:347-353.
48.Fardig JA. A comparison of skin-to-skin contact and radiant heaters in promoting neonatal thermoregulation. J Nurse Midwifery. 1980;25:19-28.
49.Wiberg B, Humble K, de Chateau P. Long-term effect on mother-infant behaviour of extra contact during the first hour post partum (V. Follow-up at three years). Scand J Soc Med. 1989;17:181-191.
50.Carrasco M, Martell M, Estol PC. Oronasopharyngeal suction at birth: Effects on arterial oxygen saturation. J Pediatr. 1997;130:832-834.
51.Estol PC, Piriz H, Basalo S, Simini F, Grela C. Oro-naso-pharyngeal suction at birth: Effects on respiratory adaptation of normal term vaginally born infants. J Perinat Med. 1992;20:297-305.
52.Waltman PA, Brewer JM, Rogers BP, May WL. Building evidence for practice: A pilot study of newborn bulb suctioning at birth. J Midwifery Womens Health. 2004;49:32-38.
53.Cordero L, Hon EH. Neonatal bradycardia following nasopharyngeal stimulation. J Pediatr. 1971;78:441-447.
54.Fraser WD, Hofmeyr J, Lede R, Faron G, Alexander S, Goffinet F, et al.. Amnioinfusion for the prevention of the meconium aspiration syndrome. N Engl J Med. 2005;353:909-917.
55.Vain NE, Szyld EG, Prudent LM, Wiswell TE, Aguilar AM, Vivas NI. Oropharyngeal and nasopharyngeal suctioning of meconium-stained neonates before delivery of their shoulders: Multicentre, randomised controlled trial. Lancet. 2004;364:597-602.
56.Wiswell TE, Gannon CM, Jacob J, Goldsmith L, Szyld E, Weiss K, et al.. Delivery room management of the apparently vigorous meconium-stained neonate: Results of the multicenter, international collaborative trial. Pediatrics. 2000;105:1-7.
57.Velaphi S, Vidyasagar D. Intrapartum and postdelivery management of infants born to mothers with meconium-stained amniotic fluid: evidence-based recommendations. Clin Perinatol. 2006;33:29-42.
58.Carson BS, Losey RW, Bowes WA, Simmons MA. Combined obstetric and pediatric approach to prevent meconium aspiration syndrome. Am J Obstet Gynecol. 1976;126:712-715.
59.Ting P, Brady JP. Tracheal suction in meconium aspiration. Am J Obstet Gynecol. 1975;122:767-771.
60.Cohen-Addad N, Chatterjee M, Bautista A. Intrapartum suctioning of meconium: Comparative efficacy of bulb syringe and De Lee catheter. J Perinatol. 1987;7:111-113.
61.Hageman JR, Conley M, Francis K, Stenske J, Wolf I, Santi V, et al.. Delivery room management of meconium staining of the amniotic fluid and the development of meconium aspiration syndrome. J Perinatol. 1988;8:127-131.
62.Locus P, Yeomans E, Crosby U. Efficacy of bulb versus DeLee suction at deliveries complicated by meconium stained amniotic fluid. Am J Perinatol. 1990;7:87-91.
63.Widstrom AM, Ransjo-Arvidson AB, Christensson K, Matthiesen AS, Winberg J, Uvnas-Moberg K. Gastric suction in healthy newborn infants (Effects on circulation and developing feeding behaviour). Acta Paediatr Scand. 1987;76:566-572.
64.Lundstrom KE, Pryds O, Greisen G. Oxygen at birth and prolonged cerebral vasoconstriction in preterm infants. Arch Dis Child Fetal Neonatal Ed. 1995;73:F81-F86.
65.Ramji S, Ahuja S, Thirupuram S, Rootwelt T, Rooth G, Saugstad OD. Resuscitation of asphyxic newborn infants with room air or 100% oxygen. Pediatr Res. 1993;34:809-812.
66.Ramji S, Rasaily R, Mishra PK, Narang A, Jayam S, Kapoor AN, et al.. Resuscitation of asphyxiated newborns with room air or 100% oxygen at birth: A multicentric clinical trial. Indian Pediatr. 2003;40:510-517.
67.Saugstad OD. Resuscitation with room-air or oxygen supplementation. Clin Perinatol. 1998;25:741- 756.
68.Vento M, Asensi M, Sastre J, Garcia-Sala F, Pallardo FV, Vina J. Resuscitation with room air instead of 100% oxygen prevents oxidative stress in moderately asphyxiated term neonates. Pediatrics. 2001;107:642-647.
69.Vento M, Asensi M, Sastre J, Lloret A, Garcia-Sala F, Vina J. Oxidative stress in asphyxiated term infants resuscitated with 100% oxygen. J Pediatr. 2003;142:240-246.
70.Tan A, Schulze A, O’Donnell C, Davis P. Air versus oxygen for resuscitation of infants at birth. Cochrane Database Syst Rev. 2005;(2):CD002273.
71.Saugstad OD, Ramji S, Irani SF, El-Meneza S, Hernandez EA, Vento M, et al.. Resuscitation of newborn infants with 21% or 100% oxygen: follow-up at 18 to 24 months. Pediatrics. 2003;112:296- 300.
72.Silverman WA. The lesson of retrolental fibroplasia. Sci Am. 1977;236:100-107.
73.Rahilly PM. Effects of 2% carbon dioxide, 0.5% carbon dioxide, and 100% oxygen on cranial blood flow of the human neonate. Pediatrics. 1980;66:685-689.
74.Leahy FA, Cates D, MacCallum M, Rigatto H. Effect of CO2 and 100% O2 on cerebral blood flow in preterm infants. J Appl Physiol. 1980;48:468-472.
75.Saugstad OD, Rootwelt T, Aalen O. Resuscitation of asphyxiated newborn infants with room air or oxygen: An international controlled trial: the Resair 2 study. Pediatrics. 1998;102:e1.
76.In: Kattwinkel J editors. Textbook of neonatal resuscitation. Washington, DC: American Academy of Pediatrics; 2006;.
77.McGowan JE, Perlman JM. Glucose management during and after intensive delivery room resuscitation. Clin Perinatol. 2006;33:183-196.
SHIATSU-TORINO 